In Ah Park

1.4k citations
28 papers · 1.1k indexed · h-index 19
Topics
Cancer Immunotherapy and Biomarkers (9 papers)Immunotherapy and Immune Responses (9 papers)Immune Cell Function and Interaction (5 papers)

In The Last Decade

In Ah Park

28 papers receiving 1.1k citations

Peers

In Ah Park
Comparison fields: 5 of 62
  • Oncology 765
  • Immunology 550
  • Molecular Biology 252
  • Cancer Research 215
  • Pulmonary and Respiratory Medicine 137
Replace Hiroshi Yamaguchi with:
Hiroshi Yamaguchi Japan
Gengtai Ye China
Laia Bassaganyas Spain
Hojabr Kakavand Australia
Shipra Das United States
Yacine Barèche Belgium
Qiu-Zhong Pan China
Sufei Zheng China
Piera Maggiora Italy
Zehang Jiang China
In Ah Park relative to Hiroshi Yamaguchi Japan Hiroshi Yamaguchi's profile →
Citations per field
00.5×4.4×
Hiroshi Yamaguchi · 1×
Citations per year

Countries citing papers authored by In Ah Park

Since Specialization
Citations

This map shows the geographic impact of In Ah Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by In Ah Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites In Ah Park more than expected).

Fields of papers citing papers by In Ah Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by In Ah Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by In Ah Park. The network helps show where In Ah Park may publish in the future.

Co-authorship network of co-authors of In Ah Park

This figure shows the co-authorship network connecting the top 25 collaborators of In Ah Park. A scholar is included among the top collaborators of In Ah Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with In Ah Park. In Ah Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 18
3 86
4 31
5 27
6 90
7 99
8 5
9 7
10 54
11 23
12
Activation of the PERK-eIF2α Pathway Is Associated with Tumor-infiltrating Lymphocytes in HER2-Positive Breast Cancer.
15
13 8
14 132
15 102
16 25
17 51
18 18
19 26
20 14

About In Ah Park

In Ah Park is a scholar working on Oncology, Immunology and Clinical Biochemistry, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (9 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Oncology (765 citations), Immunology (550 citations) and Cancer Research (215 citations). In Ah Park has collaborated with scholars based in South Korea, United States and India. Frequent co-authors include Gyungyub Gong, In Hye Song, Hee Jin Lee, Jong Han Yu, Sun‐Hee Heo, Young‐Ae Kim, Joo Young Kim, Hye Seon Park, Won Seon Bang and Jin‐Hee Ahn. Their work appears in journals such as PLoS ONE, Journal of Clinical Pathology and Annals of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026